Inspire Medical Systems Announces a Positive Coverage Policy Issued by Horizon Blue Cross Blue Shield of New Jersey

Inspire Medical Systems (NYSE:INSP) a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), announced today that Horizon Blue Cross Blue Shield of New Jersey has issued a positive coverage policy of Inspire therapy.

As quoted in the press release:

This is the second coverage policy issued by a Blue Cross Blue Shield Association (“BCBSA”) healthcare plan following BCBSA Evidence Street’s January 7, 2019 report, which stated that there is sufficient evidence to determine that Inspire therapy results in a meaningful improvement in net health outcomes for patients meeting specified criteria.

Horizon BCBSNJ, an independent licensee of BCBSA, is the state of New Jersey’s largest insurer and covers approximately 3.8 million members. The Horizon BCBSNJ policy became effective January 15, 2019. This Horizon BCBSNJ also includes coverage for adolescents who have Down’s syndrome. It is important to note that this indication is not yet approved by the Food and Drug Administration (FDA).

Click here to read the full press release.